Mynd_Logo_2.png
MENU
mynd-menu.png
MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – M
Mynd Life Sciences
  • Oct 7, 2021

MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – M

MYND Diagnostics was formed to commercialize proprietary biomarker diagnostic tests for patients suffering from MDD, TRD and other...
Mynd Life Sciences
  • Sep 29, 2021

MYND Life Sciences Inc. Announces RSU Grant

VANCOUVER, BC, Sept. 29, 2021 /CNW/ – MYND Life Sciences Inc. (“MYND” or the “Company“), has granted an aggregate of 234,192 restricted...
Mynd Life Sciences
  • Sep 9, 2021

MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit Offer

VANCOUVER, BC, Sept. 9, 2021 /CNW/ – MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) (“MYND” or the “Company“) is pleased to announce,...
34
5
67
6243633205_d7126ef00c_o_edited.jpg
MYND-FUTURE.png
DIAGNOSTICS
INVESTING
SCIENCE

 
CONTACT
NEWS
  • Twitter
  • Instagram
  • LinkedIn
  • Facebook

© Copyright Mynd Life Sciences 2022

Privacy